Treatment of Neuropathic Sensitization Disorders
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Sep 26, 2024
app pub date -
Jan 10, 2022
filing date -
Jan 11, 2021
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Among others, the present invention provides a method for treating a neuropathic ocular pain disorder in a subject in need thereof, comprising: topically applying a therapeutically effective amount of a 1-di-isopropyl-phosphinoyl-alkane (DIPA) compound onto an ocular surface of the subject for at least one week, wherein the DIPA compound is dissolved in a liquid vehicle which is adapted for focused delivery of the DIPA compound to the ocular surface.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully